Bruno Julianne 4
4 · CRISPR Therapeutics AG · Filed Oct 18, 2024
Insider Transaction Report
Form 4
Bruno Julianne
Chief Operating Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-10-16+18,333→ 18,333 totalExercise: $49.00Exp: 2034-10-16→ Common Shares (18,333 underlying)
Footnotes (1)
- [F1]This option was granted on October 16, 2024 with respect to 18,333 Common Shares. 100% of the shares will vest in 48 equal monthly installments, with the first vesting date of November 16, 2024.